D-0451-2017 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Princeton, NJ

FDA drug recall D-0451-2017 was initiated by Dr. Reddy's Laboratories, Inc. on Dec 28, 2016 and is designated Class II. Reason for recall: Failed Dissolution Specifications; 18 month stability time point The recall status is terminated (terminated Oct 19, 2017). Affected quantity: 59,440 blister cards.

Recall details

Product Type
Drugs
Report Date
Feb 8, 2017
Initiation Date
Dec 28, 2016
Termination Date
Oct 19, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
59,440 blister cards

Product description

Flucanozole Tablets, USP, 150 mg, 12x1 Blister cards, Rx Only, Mfd. by: Dr. Reddy's Laboratories, Bachupally 500 090 India --- NDC 55111-145-12

Reason for recall

Failed Dissolution Specifications; 18 month stability time point

Distribution pattern

Nationwide

Code information

C500222, C500515, and C500517, exp 12/2016, C502343, exp 03/2017

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0451-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0451-2017. Report a data issue: hello@regdatalab.com.